Prostatic Neoplasms, Castration-Resistant: Clinical Trials

3 trials for Prostatic Neoplasms, Castration-Resistant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Active not recruiting 1, Completed 1, Recruiting 1

Follow Prostatic Neoplasms, Castration-Resistant: new trials by email Literature Review of Prostatic Neoplasms, Castration-Resistant trials Research Report on Prostatic Neoplasms, Castration-Resistant

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
18F-Fluciclovine PET/CT Scan - Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant
Phase 4RecruitingVA Greater Los Angeles Healthcare System152024-12-152024-11-27
Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects
Enzalutamide - Prostatic Neoplasms, Castration-Resistant
Phase 4CompletedRadboud University Medical Center572019-05-302024-06-12
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
GnRH agonist/antagonist, Prednisone, Abiraterone Acetate - Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma
Phase 4Active not recruitingNorthwestern University1002017-03-312026-02-24

Narrower conditions

Prostatic Neoplasms (2)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Prostatic Diseases (1)  ·  Urogenital Neoplasms (1)

Broader conditions

Genital Diseases (3)  ·  Urogenital Diseases (3)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Prostatic Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognition Disorders (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Mental Disorders (1)

Interventions

enzalutamide (2)  ·  Abiraterone Acetate (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Prednisone (1)

Sponsors

Northwestern University (1)  ·  Radboud University Medical Center (1)  ·  VA Greater Los Angeles Healthcare System (1)

Countries

United States (2)  ·  Netherlands (1)

Top investigators

David VanderWeele, M.D., M.P.H. (1)

Results publications

PMID 38485614